FINE FOODS & PHARMACEUTICALS (FF.MI) Stock Price & Overview

BIT:FF • IT0005215329

11.25 EUR
-0.4 (-3.43%)
Last: Mar 3, 2026, 07:00 PM

The current stock price of FF.MI is 11.25 EUR. Today FF.MI is down by -3.43%. In the past month the price increased by 7.66%. In the past year, price increased by 56.25%.

FF.MI Key Statistics

52-Week Range6.46 - 11.9
Current FF.MI stock price positioned within its 52-week range.
1-Month Range10.2 - 11.9
Current FF.MI stock price positioned within its 1-month range.
Market Cap
248.175M
P/E
12.64
Fwd P/E
16.02
EPS (TTM)
0.89
Dividend Yield
1.21%

FF.MI Stock Performance

Today
-3.43%
1 Week
-3.85%
1 Month
+7.66%
3 Months
+17.92%
Longer-term
6 Months +29.31%
1 Year +56.25%
2 Years +34.89%
3 Years +35.54%
5 Years -5.06%
10 Years N/A

FF.MI Stock Chart

FINE FOODS & PHARMACEUTICALS / FF Daily stock chart

FF.MI Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to FF.MI. When comparing the yearly performance of all stocks, FF.MI is one of the better performing stocks in the market, outperforming 87.95% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
FF.MI Full Technical Analysis Report

FF.MI Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to FF.MI. FF.MI has an average financial health and profitability rating.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
FF.MI Full Fundamental Analysis Report

FF.MI Earnings

Next Earnings DateMar 11, 2026
Last Earnings DateNov 6, 2025
PeriodQ3 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %
FF.MI Earnings History

FF.MI Forecast & Estimates

12 analysts have analysed FF.MI and the average price target is 13.12 EUR. This implies a price increase of 16.6% is expected in the next year compared to the current price of 11.25.

For the next year, analysts expect an EPS growth of 53.89% and a revenue growth 4.41% for FF.MI


Analysts
Analysts86.67
Price Target13.12 (16.62%)
EPS Next Y53.89%
Revenue Next Year4.41%
FF.MI Forecast & Estimates

FF.MI Groups

Sector & Classification

FF.MI Financial Highlights

Over the last trailing twelve months FF.MI reported a non-GAAP Earnings per Share(EPS) of 0.89. The EPS increased by 147.03% compared to the year before.


Income Statements
Revenue(TTM)373.66M
Net Income(TTM)18.62M
Industry RankSector Rank
PM (TTM) 5.07%
ROA 6.89%
ROE 13.58%
Debt/Equity 0.44
Chartmill High Growth Momentum
EPS Q2Q%3.62%
Sales Q2Q%12.18%
EPS 1Y (TTM)147.03%
Revenue 1Y (TTM)1.78%
FF.MI financials

FF.MI Ownership

Ownership
Inst Owners12%
Shares22.06M
Float9.22M
Ins Owners53.17%
Short Float %N/A
Short RatioN/A
FF.MI Ownership

FF.MI Competitors/Peers

The largest stocks on the EU markets in the "Life Sciences Tools & Services" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
SRT3 SARTORIUS AG-VORZUG37.1217.994B
DIM SARTORIUS STEDIM BIOTECH31.317.49B
56S1 SARTORIUS STEDIM BIOTECH33.6617.485B
SRT SARTORIUS AG29.4513.868B
QIA QIAGEN N.V.17.678.507B
1SXP SCHOTT PHARMA AG& CO KGAA12.42.19B
EVT EVOTEC SE N/A2.019B
GXI GERRESHEIMER AG5.37556.785M
ALECR EUROFINS CEREP-REGR N/A159M
MLC MALIN CORP PLC N/A

About FF.MI

Company Profile

FF logo image Fine Foods & Pharmaceuticals N.T.M. The company is headquartered in Verdellino, Bergamo and currently employs 660 full-time employees. The company went IPO on 2016-10-19. The company is specialized in the manufacturing of pharmaceutical products for third parties. The firm manages three segments: Pharmaceuticals, Nutraceuticals and Medical Devices. The Pharmaceuticals segment includes powders and granules, tablets, coated tablets and hard gelatin capsules, packaged in sachets, blisters and bottles. The Nutraceuticals segment includes soluble and effervescent powders and granules, soluble, effervescent and chewable tablets, coated tablets and hard gelatin capsules packaged in bags, sachets, sticks, jars, tablet bottles, blisters and strips. The Medical Devices segment includes tablets, capsules, powders, granules and cover the areas for gastrointestinal, oral and throat treatment and the weight management. Medical Devices marked CE (European Conformity) are available for licensing.

Company Info

FINE FOODS & PHARMACEUTICALS

Via Berlino, 39, Zingonia

Verdellino BERGAMO IT

Employees: 779

FF Company Website

FF Investor Relations

Phone: 390354821382

FINE FOODS & PHARMACEUTICALS / FF.MI FAQ

What does FF do?

Fine Foods & Pharmaceuticals N.T.M. The company is headquartered in Verdellino, Bergamo and currently employs 660 full-time employees. The company went IPO on 2016-10-19. The company is specialized in the manufacturing of pharmaceutical products for third parties. The firm manages three segments: Pharmaceuticals, Nutraceuticals and Medical Devices. The Pharmaceuticals segment includes powders and granules, tablets, coated tablets and hard gelatin capsules, packaged in sachets, blisters and bottles. The Nutraceuticals segment includes soluble and effervescent powders and granules, soluble, effervescent and chewable tablets, coated tablets and hard gelatin capsules packaged in bags, sachets, sticks, jars, tablet bottles, blisters and strips. The Medical Devices segment includes tablets, capsules, powders, granules and cover the areas for gastrointestinal, oral and throat treatment and the weight management. Medical Devices marked CE (European Conformity) are available for licensing.


Can you provide the latest stock price for FINE FOODS & PHARMACEUTICALS?

The current stock price of FF.MI is 11.25 EUR. The price decreased by -3.43% in the last trading session.


What is the dividend status of FINE FOODS & PHARMACEUTICALS?

FINE FOODS & PHARMACEUTICALS (FF.MI) has a dividend yield of 1.21%. The yearly dividend amount is currently 0.12.


What is the ChartMill technical and fundamental rating of FF stock?

FF.MI has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


What is the analyst forecast for FF.MI stock?

12 analysts have analysed FF.MI and the average price target is 13.12 EUR. This implies a price increase of 16.6% is expected in the next year compared to the current price of 11.25.


Can you provide the growth outlook for FINE FOODS & PHARMACEUTICALS?

The Revenue of FINE FOODS & PHARMACEUTICALS (FF.MI) is expected to grow by 4.41% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.